CN106344739A - 一种外用抗癌中药膏、其制备方法以及应用 - Google Patents
一种外用抗癌中药膏、其制备方法以及应用 Download PDFInfo
- Publication number
- CN106344739A CN106344739A CN201610753740.1A CN201610753740A CN106344739A CN 106344739 A CN106344739 A CN 106344739A CN 201610753740 A CN201610753740 A CN 201610753740A CN 106344739 A CN106344739 A CN 106344739A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- chinese medicinal
- externally applied
- medicinal ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title abstract description 4
- 239000011505 plaster Substances 0.000 title abstract 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 22
- 241001116389 Aloe Species 0.000 claims abstract description 20
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 20
- 239000009670 cang er zi wan Substances 0.000 claims abstract description 20
- 238000011282 treatment Methods 0.000 claims abstract description 18
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 12
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 12
- 206010005003 Bladder cancer Diseases 0.000 claims abstract description 11
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims abstract description 11
- 201000005112 urinary bladder cancer Diseases 0.000 claims abstract description 11
- 239000002674 ointment Substances 0.000 claims description 33
- 241000628997 Flos Species 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 22
- 241000756943 Codonopsis Species 0.000 claims description 19
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 19
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 10
- 235000002791 Panax Nutrition 0.000 claims description 7
- 241000208343 Panax Species 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003560 cancer drug Substances 0.000 claims description 2
- 241000972155 Moschus Species 0.000 claims 4
- 208000002193 Pain Diseases 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 14
- 210000004881 tumor cell Anatomy 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000002147 killing effect Effects 0.000 abstract description 4
- 230000006907 apoptotic process Effects 0.000 abstract description 3
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract description 2
- 241000576429 Forsythia suspensa Species 0.000 abstract description 2
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract description 2
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 230000004565 tumor cell growth Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000168525 Croton tiglium Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract 1
- 229960002594 arsenic trioxide Drugs 0.000 abstract 1
- GOLCXWYRSKYTSP-UHFFFAOYSA-N arsenic trioxide Inorganic materials O1[As]2O[As]1O2 GOLCXWYRSKYTSP-UHFFFAOYSA-N 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- KTTMEOWBIWLMSE-UHFFFAOYSA-N diarsenic trioxide Chemical compound O1[As](O2)O[As]3O[As]1O[As]2O3 KTTMEOWBIWLMSE-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 12
- 239000003814 drug Substances 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000008961 swelling Effects 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 201000007227 lymph node tuberculosis Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 238000002512 chemotherapy Methods 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000001959 radiotherapy Methods 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 3
- -1 sterol compound Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241000271039 Agkistrodon Species 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000002252 panizo Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000907904 Dipterocarpus Species 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- YYSRTHIUABRSAB-UHFFFAOYSA-N Neocarthamin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(O)C2=C1C(=O)CC(C=1C=CC(O)=CC=1)O2 YYSRTHIUABRSAB-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241001423398 Ruscus hypoglossum Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- UBFTZAGDGOMJQE-SACPXRHSSA-N neocarthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C(O)=CC2=C1C(=O)C[C@@H](C=1C=CC(O)=CC=1)O2 UBFTZAGDGOMJQE-SACPXRHSSA-N 0.000 description 1
- 201000008585 noma Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229940056692 resinol Drugs 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 208000011581 secondary neoplasm Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种外用抗癌中药膏,由以下重量份的原料制成:白砒5~15份、巴豆6~14份、罂粟壳4~8份、当归3~13份、连翘4~12份、冰片5~15份、麝香1~3份、苍耳子2~8份、红花3~9份、党参5~7份、大枣15~25份、白花蛇舌草5~10份、夏枯草3~12份、芦荟8~16份、三七10~20份、冰硼散8~15份;同时公开了该外用抗癌中药膏的制备方法和应用。本发明外用抗癌中药膏原料经配伍后,清热解毒,消痛散结,活血止痛,嫩消沉痼;具有很好的抑制肿瘤细胞生长和能促进肿瘤细胞凋亡的作用,且对多种肿瘤细胞均具有强的杀灭作用,应用范围广泛,对膀胱癌治疗有独到之处,治愈率高达60~70%,无任何毒副作用,安全可靠。
Description
技术领域
本发明属于药物技术领域,具体涉及一种外用抗癌中药膏、其制备方法以及应用。
背景技术
从古至今,癌症一直严重的威胁着人的身体健康,直接影响着人的寿命。现在,每年死于癌症的人数越来越多。相关技术中,癌症的治疗方法主要包括:手术治疗、放射治疗、化学治疗、激素治疗、基因治疗和免疫治疗。其中,手术治疗、放射治疗、化学治疗由于疗效显著发展较快。
目前,西医不能手术的肿瘤多是以化疗和放疗为主,但是,抗肿瘤化疗药物以及放疗都有严重的副反应,容易引起骨髓造血障碍、胃肠道反应以及原发性二次肿瘤等。而中药在治疗肿瘤方面,相对化疗和放疗副反应较少,且能对抗肿瘤化疗和放疗造成的损伤,提高肿瘤患者的免疫指标。因此,发展治疗肿瘤的中药,在肿瘤治疗中联合用药成为趋势。
发明内容
本发明的目的在于提供一种外用抗癌中药膏、其制备方法以及应用。
为实现上述目的,本发明采用如下技术方案:
一种外用抗癌中药膏,由以下重量份的原料制成:白砒5~15份、巴豆6~14份、罂粟壳4~8份、当归3~13份、连翘4~12份、冰片5~15份、麝香1~3份、苍耳子2~8份、红花3~9份、党参5~7份、大枣15~25份、白花蛇舌草5~10份、夏枯草3~12份、芦荟8~16份、三七10~20份、冰硼散8~15份。
优选的,一种外用抗癌中药膏,由以下重量份的原料制成:白砒8~12份、巴豆9~11份、罂粟壳5~7份、当归6~10份、连翘7~9份、冰片9~11份、麝香1.5~2.5份、苍耳子4~6份、红花5~7份、党参5.5~6.5份、大枣18~22份、白花蛇舌草7~9份、夏枯草8~10份、芦荟10~14份、三七14~16份、冰硼散10~12份。
优选的,一种外用抗癌中药膏,由以下重量份的原料制成:白砒10份、巴豆10份、罂粟壳6份、当归8份、连翘8份、冰片10份、麝香2份、苍耳子5份、红花6份、党参6份、大枣20份、白花蛇舌草8份、夏枯草9份、芦荟12份、三七15份、冰硼散11份。
上述外用抗癌中药膏的制备方法,包括以下步骤:(1)将巴豆、罂粟壳、当归、连翘、麝香、苍耳子、红花、党参、大枣、白花蛇舌草、夏枯草、芦荟、三七混合粉碎均匀后得混合物,加入混合物质量6-8倍的水,煮沸2-5h后,过滤得滤液和滤渣;
(2)将滤液在60-80℃蒸馏提纯1-3小时得提纯液,向提纯液中加入白砒、冰硼散和冰片混合均匀得混合液;将滤渣粉碎至100-300目,然后与混合液混合均匀即可。
本发明外用抗癌中药膏对各种肿瘤有一定的治疗效果,可以作为治疗各种肿瘤的药物进行应用,特别的对膀胱癌的治疗有独到之处,可以作为治疗膀胱癌药物的进行应用,进行推广。本发明外用抗癌中药膏使用时为外用涂抹,根据需要每天选择涂抹次数。
本发明的各原料药用机理为:
白砒:性味:辛、酸、热,大毒;功能主治:蚀疮,杀虫,劫痰,截疟;主治痔疮,瘰疬,痈疽恶疮,走马牙疳,癣疮,寒痰哮喘,疟疾,休息痢。
巴豆为大戟科巴豆属植物巴豆树的干燥成熟果实,其根及叶亦供药用。巴豆树为常绿乔木,高6~10米。巴豆是一种常用的中草药,其味辛性热,有下泻毒性。呕吐、腹泻、白细胞升高等是巴豆中毒的主要表现。中医药上以果实入药,性热,味辛,功能破积、逐水、涌吐痰涎,有助于治寒结便秘、腹水肿胀、寒邪食积所致的胸腹胀满急痛、大便不通、泄泻痢疾、水肿腹大、痰饮喘满、喉风喉痹、痈疽、恶疮疥癣,能峻下积滞,逐水消肿,外用蚀疮。
罂粟壳:敛肺,涩肠,止痛。用于久咳,久泻,脱肛,脘腹疼痛。
当归:性味:甘、辛、温。归经:归肝、心、脾经。功能主治:补血;活血;调经止痛;润燥滑肠。主血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。
连翘:果实含连翘酚、甾醇化合物、皂甙(无溶血性)及黄酮醇甙类、马苔树脂醇甙等。抗菌作用连翘浓缩煎剂在体外有抗菌作用,可抑制伤寒杆菌、副伤寒杆菌、大肠杆菌、痢疾杆菌、白喉杆菌及霍乱弧菌、葡萄球菌、链球菌等。主治清热解毒,消肿散结,疏散风热,有“疮家圣药”之称。治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭,清心火。
冰片,又名片脑、桔片、艾片、龙脑香、梅花冰片、羯布罗香、梅花脑、冰片脑、梅冰等,是由菊科艾纳香茎叶或樟科植物龙脑樟枝叶经水蒸汽蒸馏并重结晶而得;味辛、苦,微寒;归心、肝、肺经;清香宣散,具有开窍醒神,清热散毒,明目退翳的功效,主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮睛。
麝香,性味归经:辛,温,归心、脾经。功效:开窍醒神,活血通经,止痛,催产。
苍耳子:菊科植物苍耳的干燥成熟带总苞的果实。性味:味苦、甘、辛,性温。归经:归肺、肝经。功效:发散风寒,通鼻窍,祛风湿,止痛。主治:用于风寒感冒,鼻渊,风湿痹痛,风疹瘙痒等证。
红花:含红花甙、新红花甙、红花醌甙、红花多糖、棕榈酸、肉桂酸、月桂酸。性温,味辛。主治活血通经,散淤止痛,用于闭经,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。
党参:具有补中益气,健脾益肺的功效。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴等。性味归经:性平,味甘、微酸。归脾、肺经。
大枣又名红枣、干枣、枣子,大枣味甘、性温,归脾、胃经,富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分,其中维生素C的含量在果品中名列前茅,有维生素王之美称。中医中药理论认为,大枣具有补虚益气、养血安神、健脾和胃等作用,对慢性肝炎、肝硬化、贫血、过敏性紫癜等病症有较好疗效,是脾胃虚弱、气血不足、倦怠无力、失眠多梦等患者良好的保健营养品。大枣所含有的环磷酸腺苷是人体细胞能量代谢的必需成分,能够增强肌力、消除疲劳、扩张血管、增加心肌收缩力、改善心肌营养,对防治心血管系统疾病有良好的作用;含有的三萜类化合物有较强的抗癌、抗过敏作用。
白花蛇舌草味辛、甘,大热。归肾、脾、心、肝经。补火助阳,引火归源,散寒止痛,活血通经。
夏枯草苦、辛,寒。多用来散结消肿,治瘰疬、瘿瘤、乳痈肿痛。《本草从新》载其:治瘰疬、鼠瘘、瘿瘤、症坚、乳痈、乳岩。夏枯草为清肝火、散郁结的要药,它所主治的大多是肝经的病症。本品配以菊花、决明子,可清肝明目,治目赤肿痛、配以石决明、钩藤,可平降肝阳,治头痛、头晕;配以玄参、贝母、牡蛎等品,可软坚散结,治瘰历结核。近年来临床上用于肿瘤。
芦荟含有有效成分为芦荟甙,其性苦寒,入心、肝、胃、大肠经。且对口腔炎、肠炎、便秘、皮肤病、糖尿病和感染等有预防和治疗作用,还可增强身体素质,提高人体自身免疫力。芦荟本身含丰富的维生素、蛋白质、铁、钙、钾、磷、镁、锌等多种矿物质以及谷氨酸、精氨酸、果糖等容易被肌肤吸收,还对预防心脑血管病、口腔炎症和便秘有明显疗效。
三七:性温、味甘、微苦、无毒、归肝、胃经。功能:止血;散血;定痛。主治:跌扑瘀肿,胸痹绞痛,症瘕;血瘀经闭;痛经;产后瘀阴腹痛;疮痈肿痛。
冰硼散清热解毒,消肿止痛。用于热毒蕴结所致的咽喉疼痛,牙龈肿痛,口舌生疮。
本发明的有益效果为:本发明外用抗癌中药膏原料经配伍后,清热解毒,消痛散结,活血止痛,嫩消沉痼;本发明外用抗癌中药膏外用,具有很好的抑制肿瘤细胞生长和能促进肿瘤细胞凋亡的作用,且对多种肿瘤细胞均具有强的杀灭作用,应用范围广泛,对膀胱癌治疗有独到之处,疗效好,30天左右见效,治愈率高达60~70%,无任何毒副作用,安全可靠。
具体实施方式
下面结合实施例对本发明做进一步的说明,但本发明的保护范围并不仅限于此。
实施例1
一种外用抗癌中药膏,由以下重量份的原料制成:白砒10份、巴豆10份、罂粟壳6份、当归8份、连翘8份、冰片10份、麝香2份、苍耳子5份、红花6份、党参6份、大枣20份、白花蛇舌草8份、夏枯草9份、芦荟12份、三七15份、冰硼散11份。
外用抗癌中药膏的制备方法,包括以下步骤:(1)将巴豆、罂粟壳、当归、连翘、麝香、苍耳子、红花、党参、大枣、白花蛇舌草、夏枯草、芦荟、三七混合粉碎均匀后得混合物,加入混合物质量7倍的水,煮沸3.5h后,过滤得滤液和滤渣;
(2)将滤液在70℃蒸馏提纯2小时得提纯液,向提纯液中加入白砒、冰硼散和冰片混合均匀得混合液;将滤渣粉碎至200目,然后与混合液混合均匀即可。
实施例2
一种外用抗癌中药膏,由以下重量份的原料制成:白砒5份、巴豆6份、罂粟壳4份、当归3份、连翘4份、冰片5份、麝香1份、苍耳子2份、红花3份、党参5份、大枣15份、白花蛇舌草5份、夏枯草3份、芦荟8份、三七10份、冰硼散8份。
外用抗癌中药膏的制备方法,包括以下步骤:(1)将巴豆、罂粟壳、当归、连翘、麝香、苍耳子、红花、党参、大枣、白花蛇舌草、夏枯草、芦荟、三七混合粉碎均匀后得混合物,加入混合物质量6倍的水,煮沸2h后,过滤得滤液和滤渣;
(2)将滤液在60℃蒸馏提纯1小时得提纯液,向提纯液中加入白砒、冰硼散和冰片混合均匀得混合液;将滤渣粉碎至100目,然后与混合液混合均匀即可。
实施例3
一种外用抗癌中药膏,由以下重量份的原料制成:白砒15份、巴豆14份、罂粟壳8份、当归13份、连翘12份、冰片15份、麝香3份、苍耳子8份、红花9份、党参7份、大枣25份、白花蛇舌草10份、夏枯草12份、芦荟16份、三七20份、冰硼散15份。
外用抗癌中药膏的制备方法,包括以下步骤:(1)将巴豆、罂粟壳、当归、连翘、麝香、苍耳子、红花、党参、大枣、白花蛇舌草、夏枯草、芦荟、三七混合粉碎均匀后得混合物,加入混合物质量8倍的水,煮沸5h后,过滤得滤液和滤渣;
(2)将滤液在80℃蒸馏提纯3小时得提纯液,向提纯液中加入白砒、冰硼散和冰片混合均匀得混合液;将滤渣粉碎至300目,然后与混合液混合均匀即可。
实施例4
一种外用抗癌中药膏,由以下重量份的原料制成:白砒8份、巴豆9份、罂粟壳5份、当归6份、连翘7份、冰片9份、麝香1.5份、苍耳子4份、红花5份、党参5.5份、大枣18份、白花蛇舌草7份、夏枯草8份、芦荟10份、三七14份、冰硼散10份。
外用抗癌中药膏的制备方法,包括以下步骤:(1)将巴豆、罂粟壳、当归、连翘、麝香、苍耳子、红花、党参、大枣、白花蛇舌草、夏枯草、芦荟、三七混合粉碎均匀后得混合物,加入混合物质量6.5倍的水,煮沸4h后,过滤得滤液和滤渣;
(2)将滤液在65℃蒸馏提纯2.5小时得提纯液,向提纯液中加入白砒、冰硼散和冰片混合均匀得混合液;将滤渣粉碎至150目,然后与混合液混合均匀即可。
实施例5
一种外用抗癌中药膏,由以下重量份的原料制成:白砒12份、巴豆11份、罂粟壳7份、当归10份、连翘9份、冰片11份、麝香2.5份、苍耳子6份、红花7份、党参6.5份、大枣22份、白花蛇舌草9份、夏枯草10份、芦荟14份、三七16份、冰硼散12份。
外用抗癌中药膏的制备方法,包括以下步骤:(1)将巴豆、罂粟壳、当归、连翘、麝香、苍耳子、红花、党参、大枣、白花蛇舌草、夏枯草、芦荟、三七混合粉碎均匀后得混合物,加入混合物质量7.3倍的水,煮沸2.8h后,过滤得滤液和滤渣;
(2)将滤液在76℃蒸馏提纯2.4小时得提纯液,向提纯液中加入白砒、冰硼散和冰片混合均匀得混合液;将滤渣粉碎至250目,然后与混合液混合均匀即可。
为了进一步验证本发明外用抗癌中药膏的效果,选用实施例1中的产品进行临床试验,试验对象为50例,其中胃癌10例,肝癌10例,膀胱癌30例,使用方法为:将实施例1中得到的产品均匀涂抹在接近肿瘤的位置,每天涂抹三次,30天为一疗程。使用一个疗程后,症状改善者有40例,有效率80%,其中膀胱癌患者病情症状全部改善,治愈者为21例,治愈率为70%。典型病例如下:
病例1
患者黄某:男,56岁,青岛人,患胃癌,外用本发明外用抗癌中药膏1个疗程,现还在使用,疼痛感明显减轻,进食恢复。
病例2
患者成某:男,72岁,山东人,患肝癌,外用本发明外用抗癌中药膏1个疗程,疼痛感明显减轻。
病例3
患者黄某:男,79岁,山东人,患膀胱癌,排尿困难、疼痛、并伴有尿失禁,外用本发明外用抗癌中药膏1个疗程,以上症状全部消失,经检查痊愈。
病例4
患者成某:男,55岁,济南人,患膀胱癌,手术后外用本发明外用抗癌中药膏1个疗程,排尿恢复正常,无骨痛,经检查痊愈。
病例5
患者杜某:男,41岁,济南人,患膀胱癌,外用本发明外用抗癌中药膏1个疗程,排尿得到改善,疼痛感减小,体重增加,贫血症状消失。
由以上临床试验结果可知本发明外用抗癌中药膏外用,具有很好的抑制肿瘤细胞生长和能促进肿瘤细胞凋亡的作用,且对多种肿瘤细胞均具有强的杀灭作用,应用范围广泛,对膀胱癌治疗有独到之处。
Claims (5)
1.一种外用抗癌中药膏,其特征在于,由以下重量份的原料制成:白砒5~15份、巴豆6~14份、罂粟壳4~8份、当归3~13份、连翘4~12份、冰片5~15份、麝香1~3份、苍耳子2~8份、红花3~9份、党参5~7份、大枣15~25份、白花蛇舌草5~10份、夏枯草3~12份、芦荟8~16份、三七10~20份、冰硼散8~15份。
2.如权利要求1所述的一种外用抗癌中药膏,其特征在于,由以下重量份的原料制成:白砒8~12份、巴豆9~11份、罂粟壳5~7份、当归6~10份、连翘7~9份、冰片9~11份、麝香1.5~2.5份、苍耳子4~6份、红花5~7份、党参5.5~6.5份、大枣18~22份、白花蛇舌草7~9份、夏枯草8~10份、芦荟10~14份、三七14~16份、冰硼散10~12份。
3.如权利要求2所述的一种外用抗癌中药膏,其特征在于,由以下重量份的原料制成:白砒10份、巴豆10份、罂粟壳6份、当归8份、连翘8份、冰片10份、麝香2份、苍耳子5份、红花6份、党参6份、大枣20份、白花蛇舌草8份、夏枯草9份、芦荟12份、三七15份、冰硼散11份。
4.权利要求1-3任一所述外用抗癌中药膏的制备方法,其特征在于,包括以下步骤:
(1)将巴豆、罂粟壳、当归、连翘、麝香、苍耳子、红花、党参、大枣、白花蛇舌草、夏枯草、芦荟、三七混合粉碎均匀后得混合物,加入混合物质量6-8倍的水,煮沸2-5h后,过滤得滤液和滤渣;
(2)将滤液在60-80℃蒸馏提纯1-3小时得提纯液,向提纯液中加入白砒、冰硼散和冰片混合均匀得混合液;将滤渣粉碎至100-300目,然后与混合液混合均匀即可。
5.权利要求1-3任一所述的外用抗癌中药膏作为治疗膀胱癌药物的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610753740.1A CN106344739A (zh) | 2016-08-29 | 2016-08-29 | 一种外用抗癌中药膏、其制备方法以及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610753740.1A CN106344739A (zh) | 2016-08-29 | 2016-08-29 | 一种外用抗癌中药膏、其制备方法以及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106344739A true CN106344739A (zh) | 2017-01-25 |
Family
ID=57857395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610753740.1A Pending CN106344739A (zh) | 2016-08-29 | 2016-08-29 | 一种外用抗癌中药膏、其制备方法以及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106344739A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1539455A (zh) * | 2003-10-27 | 2004-10-27 | 李林龙 | 一种具有化癌回春作用的药物组合物及其制备方法 |
CN102274317A (zh) * | 2011-04-28 | 2011-12-14 | 李亚川 | 一种治疗癌症的中药组合物及其制备方法 |
CN102579766A (zh) * | 2012-03-29 | 2012-07-18 | 翟西菊 | 一种抗肿瘤的药物 |
CN105688063A (zh) * | 2016-03-17 | 2016-06-22 | 艾金长 | 化癌消瘤外用膏 |
-
2016
- 2016-08-29 CN CN201610753740.1A patent/CN106344739A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1539455A (zh) * | 2003-10-27 | 2004-10-27 | 李林龙 | 一种具有化癌回春作用的药物组合物及其制备方法 |
CN102274317A (zh) * | 2011-04-28 | 2011-12-14 | 李亚川 | 一种治疗癌症的中药组合物及其制备方法 |
CN102579766A (zh) * | 2012-03-29 | 2012-07-18 | 翟西菊 | 一种抗肿瘤的药物 |
CN105688063A (zh) * | 2016-03-17 | 2016-06-22 | 艾金长 | 化癌消瘤外用膏 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101912468A (zh) | 治疗乳腺炎的中草药 | |
CN101112547A (zh) | 一种治疗产后自汗的中药制剂 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN102526498A (zh) | 治疗鼻咽癌放疗后毒副作用的中药、制备方法及给药方式 | |
CN104042891A (zh) | 缓解产妇大便秘结的中药组合物及其制备方法 | |
CN103505530B (zh) | 用于治疗变异性麻疹的中药组合物 | |
CN104547313B (zh) | 一种治疗肺癌、乳腺癌、淋巴癌的药物及制备方法 | |
CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
CN105169189B (zh) | 一种治疗甲减的药物 | |
CN103211964A (zh) | 一种治疗咳嗽的中药 | |
CN104383403B (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN102370924A (zh) | 治疗心痹症的中草药 | |
CN106344739A (zh) | 一种外用抗癌中药膏、其制备方法以及应用 | |
CN105106916A (zh) | 一种产后护理用中药 | |
WO2017101154A1 (zh) | 一种养胃的中药组合物及其制备方法 | |
CN105031505A (zh) | 一种治疗良性前列腺增生肥大的药物及其制备方法 | |
CN104998074A (zh) | 一种治疗胃病的中药及其制备方法 | |
CN101129832A (zh) | 一种治疗糖尿病尿路感染的中药组合物 | |
CN103816450B (zh) | 一种治疗类风湿性关节炎的中药 | |
CN107496672A (zh) | 一种清肝明目、治肝保肝的中成药 | |
CN101940773A (zh) | 治疗慢性支气管炎的中草药 | |
CN105770398A (zh) | 红景天止咳宁 | |
CN106853188A (zh) | 一种用于胆道出血症的中药组合物及其制备方法 | |
CN101112470A (zh) | 一种治疗羊水过多的中药组合物 | |
CN105597050A (zh) | 一种用于治疗和预防化疗呕吐的穴位贴敷药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170125 |
|
RJ01 | Rejection of invention patent application after publication |